David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
La-Z-Boy
LZB
$1.29B
| $7.47M | 0.01% |
226,400
+218
| +0.1% | +$6.88K |
|
1252
PUT
Capri Holdings
CPRI
$1.52B
| $7.47M | 0.01% |
163,200
+33,200
| +26% | +$1.45M |
|
1253
CALL
McDonald's
MCD
$189B
| $7.46M | 0.01% |
39,300
-45,900
| -54% | -$8.33M |
|
1254
PUT
NXP Semiconductors
NXPI
$56.4B
| $7.45M | 0.01% |
84,300
-290,100
| -77% | -$25.5M |
|
1255
PUT
TAL Education Group
TAL
$6.46B
| $7.43M | 0.01% |
205,900
-118,600
| -37% | -$3.85M |
|
|
PACW
1256
DELISTED
PacWest Bancorp
PACW
| $7.38M | 0.01% |
196,325
+4,690
| +2% | +$182K |
|
|
NUVA
1257
DELISTED
NuVasive, Inc.
NUVA
| $7.38M | 0.01% |
129,896
+48,686
| +60% | +$2.59M |
|
|
TGI
1258
DELISTED
Triumph Group
TGI
| $7.36M | 0.01% |
386,166
+221,517
| +135% | +$4.17M |
|
1259
Bank of N.T. Butterfield & Son
NTB
$2.3B
| $7.35M | 0.01% |
204,877
+13,381
| +7% | +$481K |
|
1260
CALL
Autodesk
ADSK
$53.1B
| $7.34M | 0.01% |
47,100
+20,100
| +74% | +$3M |
|
1261
uniQure
QURE
$3.48B
| $7.32M | 0.01% |
122,660
+93,003
| +314% | +$4.15M |
|
1262
Warner Bros
WBD
$72.3B
| $7.31M | 0.01% |
270,565
-1,451,257
| -84% | -$40.4M |
|
|
AZPN
1263
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $7.28M | 0.01% |
69,853
-121,879
| -64% | -$12.7M |
|
|
FRGI
1264
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $7.27M | 0.01% |
554,580
+217,420
| +64% | +$3.21M |
|
1265
Radware
RDWR
$1.2B
| $7.27M | 0.01% |
278,082
+28,275
| +11% | +$690K |
|
1266
Donnelley Financial Solutions
DFIN
$1.16B
| $7.26M | 0.01% |
488,096
+3,006
| +0.6% | +$45.2K |
|
1267
Veracyte
VCYT
$3.51B
| $7.26M | 0.01% |
290,289
+111,772
| +63% | +$2.13M |
|
1268
PUT
Merck
MRK
$381B
| $7.26M | 0.01% |
91,490
-1,230,981
| -93% | -$92.1M |
|
1269
Essential Properties Realty Trust
EPRT
$6.65B
| $7.26M | 0.01% |
371,732
+255,239
| +219% | +$4.17M |
|
|
BDSI
1270
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $7.25M | 0.01% |
1,367,479
+930,350
| +213% | +$4.25M |
|
1271
Rogers Communications
RCI
$19.9B
| $7.24M | 0.01% |
134,561
-31,718
| -19% | -$1.71M |
|
1272
Cheer Holding
CHR
$3.32M
| $7.24M | 0.01% |
487
| – | – |
|
|
COUP
1273
CALL
DELISTED
Coupa Software Incorporated
COUP
| $7.24M | 0.01% |
79,600
+64,600
| +431% | +$5.54M |
|
1274
Brady Corp
BRC
$4.45B
| $7.24M | 0.01% |
155,937
-58,265
| -27% | -$2.68M |
|
1275
CALL
Mettler-Toledo International
MTD
$28.1B
| $7.23M | 0.01% |
+10,000
| New | +$6.5M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.